Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Appointed director
CC transcript
VION PHARMACEUTICALS INC (VION) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/08/2010 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
04/08/2010 8-K Quarterly results
03/31/2010 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
03/23/2010 EFFECT Form EFFECT -
03/23/2010 EFFECT Form EFFECT -
03/23/2010 EFFECT Form EFFECT -
03/23/2010 EFFECT Form EFFECT -
03/23/2010 EFFECT Form EFFECT -
03/23/2010 EFFECT Form EFFECT -
03/23/2010 EFFECT Form EFFECT -
03/23/2010 EFFECT Form EFFECT -
03/09/2010 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Order Granting Debtor and Debtor and Debtor-in-Possession's Motion for Order Authorizing Payment of Chapter 11 Plan/Sale-Related Performance Pay to Senior Management Pursuant to Sections 105(A) and 363 of the Bankruptcy Code"
03/02/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Vion Pharmaceuticals, Inc. Monthly Operating Report filed with the United States Bankruptcy Court for the District of Delaware",
"Letter Agreement by and among Vion Pharmaceuticals, Inc. and the Official Committee of Unsecured Creditors filed with the United States Bankruptcy Court for the District of Delaware",
"VION PHARMACEUTICALS RECEIVES RESPONSE FROM FDA ON SPECIAL PROTOCOL ASSESSMENT FOR ONRIGIN&#212"
02/22/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Vion Pharmaceuticals, Inc. Monthly Operating Report filed with the United States Bankruptcy Court for the District of Delaware"
02/18/2010 8-K Form 8-K - Current report
01/25/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "VION PHARMACEUTICALS ISSUES MANAGEMENT STATEMENT REGARDING TRADING VOLUME OF COMPANY'S COMMON STOCK"
01/08/2010 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Vion Pharmaceuticals, Inc. Initial Monthly Operating Report filed with the United States Bankruptcy Court for the District of Delaware"
01/04/2010 EFFECT Form EFFECT -
01/04/2010 EFFECT Form EFFECT -
12/31/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "HOVON Trial As Designed Does Not Gain SPA Agreement"
12/30/2009 POS AM Form POS AM - Post-Effective amendments for registration statement
12/30/2009 POS AM Form POS AM - Post-Effective amendments for registration statement
12/16/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "VION PHARMACEUTICALS RECEIVES COMPLETE RESPONSE LETTER FOR ONRIGINÔ FROM THE U.S. FOOD AND DRUG ADMINISTRATION"
11/24/2009 8-K Form 8-K - Current report
11/12/2009 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/12/2009 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/10/2009 10-Q Quarterly Report for the period ended September 30, 2009
10/13/2009 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
10/13/2009 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
10/13/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "VION PHARMACEUTICALS ENGAGES MERRIMAN CURHAN FORD TO EVALUATE STRATEGIC ALTERNATIVES"
09/21/2009 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
09/10/2009 4 Cahill Ann Lee (VP Clinical Development) has filed a Form 4 on VION PHARMACEUTICALS INC
09/10/2009 4 KING IVAN (VP Research and Development) has filed a Form 4 on VION PHARMACEUTICALS INC
09/09/2009 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy